Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Notes: BMD = bone mineral density; HbA1c = glycated hemoglobin; HR = hazard ratio; TUG = timed up-and-go; 25OHD = plasma 25-hydroxyVitamin D; ucOC:tOC = ratio of undercarboxylated osteocalcin to total osteocalcin.

Source: Additional Analyses. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The study population originated from the Perth Longitudinal Study of Ageing Women (PLSAW), which includes 1 500 community-dwelling women aged 70 years or older recruited using the electoral roll.

Source: Methods.

PLSAW is composed of an initial 5-year, double-blind, randomized controlled trial investigating calcium supplementation for fracture prevention (), followed by 10 additional years of clinic visits and observation.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Apolipoprotein ɛ4 Is Associated With Increased Risk of Fall: and Fracture-Related Hospitalization: The Perth Longitudinal Study of Ageing Women

Study design awaiting verification · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · 2024

Original publication title

Apolipoprotein ɛ4 Is Associated With Increased Risk of Fall: and Fracture-Related Hospitalization: The Perth Longitudinal Study of Ageing Women

Jedd Pratt; Jack Dalla Via; Craig Sale; Abadi K Gebre; Blossom C M Stephan; Simon Laws; Kun Zhu; Wai H Lim; Richard L Prince; Joshua R Lewis; Marc Sim

© The Author(s) 2024. Published by Oxford University Press on behalf of The Gerontological Society of America.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Apolipoprotein ɛ4 (APOE ɛ4) may be a genetic risk factor for reduced bone mineral density (BMD) and muscle function, which could have implications for fall and fracture risk. We examined the association between APOE ɛ4 status and long-term fall: and fracture-related hospitalization risk in older women. A total of 1 276 community-dwelling women from the Perth Longitudinal Study of Aging Women (mean age ± SD = 75.2 ± 2.7 years) were included. At baseline, women underwent APOE genotyping and detailed phenotyping for covariates including prevalent falls and fractures, as well as health and lifestyle factors.

The association between APOE ɛ4 and fall-, any fracture-, and hip fracture-related hospitalizations, obtained over 14.5 years from linked health records, was examined using multivariable-adjusted Cox-proportional hazard models. Over 14.5 years, 507 (39.7%) women experienced a fall-related hospitalization and 360 (28.2%) women experienced a fracture-related hospitalization, including 143 (11.2%) attributed to a hip fracture. In multivariable-adjusted models, compared to noncarriers, APOE ɛ4 carriers (n = 297, 23.3%) had greater risk for a fall: (hazard ratio [HR] 1.48, 95% CI: 1.22 to 1.81), fracture: (HR 1.28, 95% CI: 1.01 to 1.63), or hip fracture-related hospitalization (HR 1.83, 95% CI: 1.29 to 2.61).

The estimates remained similar when specific fall and fracture risk factors (fear of falling, plasma 25-hydroxyvitamin D, grip strength, timed up-and-go, hip BMD, vitamin K status, prevalent diabetes, HbA1c, cholesterol, and abbreviated mental test score) were added to the multivariable model. In conclusion, APOE ɛ4 is a potential risk factor for fall: and fracture-related hospitalization in community-dwelling older women. Screening for APOE ɛ4 could provide clinicians an opportunity to direct higher-risk individuals to appropriate intervention strategies.

Authors’ abstract

Abstract

Apolipoprotein ɛ4 (APOE ɛ4) may be a genetic risk factor for reduced bone mineral density (BMD) and muscle function, which could have implications for fall and fracture risk. We examined the association between APOE ɛ4 status and long-term fall: and fracture-related hospitalization risk in older women. A total of 1 276 community-dwelling women from the Perth Longitudinal Study of Aging Women (mean age ± SD = 75.2 ± 2.7 years) were included. At baseline, women underwent APOE genotyping and detailed phenotyping for covariates including prevalent falls and fractures, as well as health and lifestyle factors.

The association between APOE ɛ4 and fall-, any fracture-, and hip fracture-related hospitalizations, obtained over 14.5 years from linked health records, was examined using multivariable-adjusted Cox-proportional hazard models. Over 14.5 years, 507 (39.7%) women experienced a fall-related hospitalization and 360 (28.2%) women experienced a fracture-related hospitalization, including 143 (11.2%) attributed to a hip fracture. In multivariable-adjusted models, compared to noncarriers, APOE ɛ4 carriers (n = 297, 23.3%) had greater risk for a fall: (hazard ratio [HR] 1.48, 95% CI: 1.22 to 1.81), fracture: (HR 1.28, 95% CI: 1.01 to 1.63), or hip fracture-related hospitalization (HR 1.83, 95% CI: 1.29 to 2.61).

The estimates remained similar when specific fall and fracture risk factors (fear of falling, plasma 25-hydroxyvitamin D, grip strength, timed up-and-go, hip BMD, vitamin K status, prevalent diabetes, HbA1c, cholesterol, and abbreviated mental test score) were added to the multivariable model. In conclusion, APOE ɛ4 is a potential risk factor for fall: and fracture-related hospitalization in community-dwelling older women. Screening for APOE ɛ4 could provide clinicians an opportunity to direct higher-risk individuals to appropriate intervention strategies.

Publication and source details

Original title: Apolipoprotein ɛ4 Is Associated With Increased Risk of Fall: and Fracture-Related Hospitalization: The Perth Longitudinal Study of Ageing Women

Jedd Pratt; Jack Dalla Via; Craig Sale; Abadi K Gebre; Blossom C M Stephan; Simon Laws; Kun Zhu; Wai H Lim; Richard L Prince; Joshua R Lewis; Marc Sim

The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · 2024

J.P. and J.D.V. contributed equally to this work and should be considered joint first authors.

Address correspondence to: Marc Sim, PhD. E-mail: marc.sim@ecu.edu.au
© The Author(s) 2024. Published by Oxford University Press on behalf of The Gerontological Society of America.2024https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. National Health and Medical Research Council10.13039/501100000925 2024225 Medical Research Future Fund 2022 Cardiovascular Health Mission Royal Perth Hospital Research Foundation Fellowship RPHRF CAF 00/21 Emerging Leader Fellowship from the Western Australian Future Health Research and Innovation Fund National Heart Foundation Future Leader Fellowship

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:09:10.918154+00:00

DOI: 10.1093/gerona/glae134 · PMC11212482